Cargando…
Mitigating the impact of COVID-19 on oncology: Clinical and operational lessons from a prospective radiation oncology cohort tested for COVID-19()
BACKGROUND AND PURPOSE: The COVID-19 pandemic warrants operational initiatives to minimize transmission, particularly among cancer patients who are thought to be at high-risk. Within our department, a multidisciplinary tracer team prospectively monitored all patients under investigation, tracking th...
Autores principales: | Ning, Matthew S., McAleer, Mary Frances, Jeter, Melenda D., Minsky, Bruce D., Ghafar, Robert A., Robinson, Ivy J., Nitsch, Paige L., Zaebst, Denise J., Todd, Sarah E., Nguyen, Jennifer, Lin, Steven H., Liao, Zhongxing, Lee, Percy, Gunn, G. Brandon, Klopp, Ann H., Dabaja, Bouthaina S., Nguyen, Quynh-Nhu, Chronowski, Gregory M., Bloom, Elizabeth S., Koong, Albert C., Das, Prajnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256609/ https://www.ncbi.nlm.nih.gov/pubmed/32474129 http://dx.doi.org/10.1016/j.radonc.2020.05.037 |
Ejemplares similares
-
Radiation Oncology Strategies to Flatten the Curve During the Coronavirus Disease 2019 (COVID-19) Pandemic: Experience From a Large Tertiary Cancer Center
por: Noticewala, Sonal S., et al.
Publicado: (2020) -
Telemedicine for Radiation Oncology in a Post-COVID World
por: Maroongroge, Sean, et al.
Publicado: (2020) -
Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancer
por: Yang, Ju, et al.
Publicado: (2017) -
Nomograms incorporating genetic variants in BMP/Smad4/Hamp pathway to predict disease outcomes after definitive radiotherapy for non‐small cell lung cancer
por: Yang, Ju, et al.
Publicado: (2018) -
Patient, physician, and policy factors underlying variation in use of telemedicine for radiation oncology cancer care
por: De, Brian, et al.
Publicado: (2022)